Kevin

Introduction

  • Presenter: Kevin, Director of Market Financial Insights at IPD Analytics.
  • Company Focus: Consulting within the pharmaceutical industry, including drug manufacturers, plan sponsors, and pharmacy benefit managers (PBMs).
  • Previous Experience: Worked in retail pharmacy at Walgreens and IB in Iowa.

Managed Care Pharmacy Overview

  • Definition: Managed care pharmacy refers to the application of clinical and scientific evidence to support the appropriate use of medications.   - Goal: Enhance patient care and health outcomes while optimizing the use of limited healthcare resources.   - Focus shifts from individual patient care to broader population health initiatives like employer-specific healthcare plans (e.g., University of Iowa employees).

Importance of Managed Care Pharmacy

  • Addresses the rising costs and challenges in healthcare, ensuring that limited resources are utilized efficiently.
  • Concept of “the right medication for the right patient at the right time.”

Programs and Strategies in Managed Care Pharmacy

  1. Pharmacy Benefit Design    - Focus: Access and coverage of treatments based on patient and population needs.    - Example Scenario: Issues encountered by patients when medications are out of network or not covered.

  2. Role of Plan Sponsors    - Definition: Entities that determine the level of coverage for medications. Examples include Hy-Vee, University of Iowa, and various Medicaid programs.    - Considerations for Plan Sponsors:
         - Budget constraints on healthcare spending.      - Geographic and demographic factors influencing healthcare needs (e.g., prevalence of sickle cell disease in specific ethnic groups and regions).

  3. Age Considerations    - Impact: Coverage tailored to the age demographics of the insured population (e.g., commercial plans vs. Medicare).

  4. Cost Management Strategies    - Importance of limiting coverage to control healthcare costs and enable better negotiation leverage with manufacturers.    

Challenges and Considerations in Managed Care Pharmacy

  • Pharmacy Benefit Managers (PBMs): Serve as administrators for plan sponsors and negotiate coverage, often subject to criticism regarding their roles and impact.
  • Formulary Design: Lists medications covered by a plan, influencing patient access and costs.   - Might include restrictions such as prior authorization and step therapy requirements:     - Prior Authorization: Ensures appropriate use and helps prevent misuse of costly medications.     - Step Therapy: Requires patients to try less expensive options before more costly medications, aimed at reducing overall costs.

Risk Stratification and Cost-Benefit Analysis in Managed Care

  • Concept of assessing the cost-effectiveness of healthcare intervention decisions based on patient profiles (e.g., a 20-something experiencing chest pain versus a 70-year-old).
  • Managed care employs risk stratification to prioritize treatments and avoid unnecessary healthcare costs.

Clinical Programs in Managed Care Pharmacy

  • Managed Programs: Led by pharmacists and technicians focusing on medication therapy management and addressing health disparities to improve medication adherence and outcomes.
  • Example: Programs for high-cost conditions like hemophilia that incur significant ongoing treatment costs.

Cost of Rare Diseases and Specialty Medications

  • Rare diseases represent a small percentage of the population but account for a substantial portion of drug costs (5% of patients incur over half of drug spending).
  • Medications for Hemophilia: Annual costs can exceed $1 million per patient, thus necessitating careful management to prevent costly hospitalizations.

Quality and Safety Programs in Managed Care

  • Medicare Part D emphasizes tracking metrics like adherence rates to medication and estimate reimbursement based on plan performance and member health outcomes.

Affordability in Managed Care Pharmacy

  • Managed care aims to reduce financial risk for individuals while protecting against misuse, fraud, and overuse of healthcare resources.
  • Value-Based Care: Payers agree to cover costly therapies based solely on successful patient outcomes.

The Complex Landscape of Payers and Manufacturers

  1. Roles of Drug Manufacturers    - Companies (e.g., Pfizer, Moderna) that develop and market drugs, providing evidence-based economic arguments for payers regarding health outcomes and costs.
  2. Payers and Insurance Companies    - Entities (health insurers) that determine coverage levels, negotiate prices, and design plans based on actuarial data.
  3. Pharmacy Benefit Managers (PBMs)    - Negotiate drug prices, determine formulary inclusion, and manage medication access for patients.
  4. Community Pharmacies    - Important in dispensing medications and providing patient counseling and adherence support.

Dynamics between Payers and Manufacturers

  • Rebates: Payments from drug manufacturers to insurers as part of formulary agreements aimed at increasing coverage and accessibility of medications.
  • Negotiation: The interaction between PBMs and manufacturers where manufacturers offer rebates for favorable formulary placement and negotiating pricing based on market share, outcomes, and competition.

Conclusion

  • The managed care pharmacy landscape is complex and involves multiple players, each with distinct roles and considerations aimed at balancing patient access, cost management, and overall health outcomes.
  • Emphasizes the importance of structured discussions, effective negotiations, and sustained focus on delivering value through collaborative efforts across the healthcare system.

Final Thoughts

  • Encourages open dialogue regarding managed care complexities and its impacts on healthcare delivery and patient outcomes. Facilitates a greater understanding of the intricacies involved in drug pricing and patient access within the pharmaceutical industry.